Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP310318.RAkmi-F_q_fHNIoiBnvU5KjNLg-LB4HOATenctcMRQWbQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP310318.RAkmi-F_q_fHNIoiBnvU5KjNLg-LB4HOATenctcMRQWbQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP310318.RAkmi-F_q_fHNIoiBnvU5KjNLg-LB4HOATenctcMRQWbQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP310318.RAkmi-F_q_fHNIoiBnvU5KjNLg-LB4HOATenctcMRQWbQ130_provenance.
- NP310318.RAkmi-F_q_fHNIoiBnvU5KjNLg-LB4HOATenctcMRQWbQ130_assertion description "[In addition to hydroxyurea, second line cytotoxic chemotherapy agents and hematopoietic cell transplant have been used for aggressive forms of HES and CEL with outcomes reported for limited numbers of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP310318.RAkmi-F_q_fHNIoiBnvU5KjNLg-LB4HOATenctcMRQWbQ130_provenance.
- NP310318.RAkmi-F_q_fHNIoiBnvU5KjNLg-LB4HOATenctcMRQWbQ130_assertion evidence source_evidence_literature NP310318.RAkmi-F_q_fHNIoiBnvU5KjNLg-LB4HOATenctcMRQWbQ130_provenance.
- NP310318.RAkmi-F_q_fHNIoiBnvU5KjNLg-LB4HOATenctcMRQWbQ130_assertion SIO_000772 21761433 NP310318.RAkmi-F_q_fHNIoiBnvU5KjNLg-LB4HOATenctcMRQWbQ130_provenance.
- NP310318.RAkmi-F_q_fHNIoiBnvU5KjNLg-LB4HOATenctcMRQWbQ130_assertion wasDerivedFrom befree-20150227 NP310318.RAkmi-F_q_fHNIoiBnvU5KjNLg-LB4HOATenctcMRQWbQ130_provenance.
- NP310318.RAkmi-F_q_fHNIoiBnvU5KjNLg-LB4HOATenctcMRQWbQ130_assertion wasGeneratedBy ECO_0000203 NP310318.RAkmi-F_q_fHNIoiBnvU5KjNLg-LB4HOATenctcMRQWbQ130_provenance.
- befree-20150227 importedOn "2015-02-27" NP310318.RAkmi-F_q_fHNIoiBnvU5KjNLg-LB4HOATenctcMRQWbQ130_provenance.